27647762|t|Theranostic Upconversion Nanobeacons for Tumor mRNA Ratiometric Fluorescence Detection and Imaging - Monitored Drug Delivery
27647762|a|Remote optical detection and imaging of specific tumor -related biomarkers and simultaneous activation of therapy according to the expression level of the biomarkers in tumor site with theranostic probes should be an effective modality for treatment of cancers. Herein, an upconversion nanobeacon (UCNPs - MB / Dox) is proposed as a new theranostic nanoprobe to ratiometrically detect and visualize the thymidine kinase 1 (TK1) mRNA that can simultaneously trigger the Dox release to activate the chemotherapy accordingly. UCNPs - MB / Dox is constructed with the conjugation of a TK1 mRNA -specific molecular beacon (MB) bearing a quencher (BHQ-1) and an alkene handle modified upconversion nanoparticle (UCNP) through click reaction and subsequently loading with a chemotherapy drug (Dox). With this nanobeacon, quantitative ratiometric upconversion detection of the target with high sensitivity and selectivity as well as the target triggered Dox release in vitro is demonstrated. The sensitive and selective ratiometric detection and imaging of TK1 mRNA under the irradiation of near infrared light (980 nm) and the mRNA -dependent release of Dox for chemotherapy in the tumor MCF-7 cells and A549 cells are also shown. This work provides a smart and robust platform for gene -related tumor theranostics.
27647762	0	36	Theranostic Upconversion Nanobeacons	T091	UMLS:C4042913
27647762	41	46	Tumor	T038	UMLS:C0027651
27647762	47	51	mRNA	T103	UMLS:C0035696
27647762	52	86	Ratiometric Fluorescence Detection	T058	UMLS:C0430876
27647762	91	98	Imaging	T058	UMLS:C0025086
27647762	111	124	Drug Delivery	T058	UMLS:C1881966
27647762	125	149	Remote optical detection	T170	UMLS:C0449335
27647762	154	161	imaging	T058	UMLS:C0011923
27647762	174	179	tumor	T038	UMLS:C0027651
27647762	189	199	biomarkers	T201	UMLS:C0005516
27647762	231	238	therapy	T058	UMLS:C0087111
27647762	256	266	expression	T038	UMLS:C1171362
27647762	280	290	biomarkers	T201	UMLS:C0005516
27647762	294	299	tumor	T038	UMLS:C0027651
27647762	300	304	site	T082	UMLS:C1515974
27647762	310	328	theranostic probes	T103	UMLS:C0026381
27647762	365	385	treatment of cancers	T058	UMLS:C0920425
27647762	431	433	MB	T103	UMLS:C2350253
27647762	436	439	Dox	T103	UMLS:C0013089
27647762	487	509	ratiometrically detect	T058	UMLS:C1511790
27647762	528	546	thymidine kinase 1	T017	UMLS:C1420747
27647762	548	551	TK1	T017	UMLS:C1420747
27647762	553	557	mRNA	T103	UMLS:C0035696
27647762	594	597	Dox	T103	UMLS:C0013089
27647762	622	634	chemotherapy	T058	UMLS:C3665472
27647762	656	658	MB	T103	UMLS:C2350253
27647762	661	664	Dox	T103	UMLS:C0013089
27647762	689	700	conjugation	T038	UMLS:C1160466
27647762	706	709	TK1	T017	UMLS:C1420747
27647762	710	714	mRNA	T103	UMLS:C0035696
27647762	725	741	molecular beacon	T103	UMLS:C2350253
27647762	743	745	MB	T103	UMLS:C2350253
27647762	757	765	quencher	T103	UMLS:C4041998
27647762	767	772	BHQ-1	T103	UMLS:C4041998
27647762	781	787	alkene	T103	UMLS:C0002068
27647762	892	909	chemotherapy drug	T103	UMLS:C0003392
27647762	911	914	Dox	T103	UMLS:C0013089
27647762	952	986	ratiometric upconversion detection	T058	UMLS:C1511790
27647762	1071	1074	Dox	T103	UMLS:C0013089
27647762	1095	1107	demonstrated	T058	UMLS:C1148554
27647762	1127	1158	selective ratiometric detection	T058	UMLS:C1511790
27647762	1163	1170	imaging	T058	UMLS:C0011923
27647762	1174	1177	TK1	T017	UMLS:C1420747
27647762	1178	1182	mRNA	T103	UMLS:C0035696
27647762	1193	1204	irradiation	T037	UMLS:C0015333
27647762	1245	1249	mRNA	T103	UMLS:C0035696
27647762	1272	1275	Dox	T103	UMLS:C0013089
27647762	1280	1292	chemotherapy	T058	UMLS:C3665472
27647762	1300	1305	tumor	T038	UMLS:C0027651
27647762	1306	1317	MCF-7 cells	T017	UMLS:C0596890
27647762	1322	1332	A549 cells	T017	UMLS:C4277577
27647762	1400	1404	gene	T017	UMLS:C0017337
27647762	1414	1419	tumor	T038	UMLS:C0027651
27647762	1420	1432	theranostics	T058	UMLS:C0087111